RED CAT HOLDINGS INC (RCAT) Fundamental Analysis & Valuation

NASDAQ:RCAT • US75644T1007

Current stock price

11.23 USD
-0.49 (-4.18%)
At close:
11.25 USD
+0.02 (+0.18%)
After Hours:

This RCAT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. RCAT Profitability Analysis

1.1 Basic Checks

  • RCAT had negative earnings in the past year.
  • RCAT had a negative operating cash flow in the past year.
  • RCAT had negative earnings in each of the past 5 years.
  • In the past 5 years RCAT always reported negative operating cash flow.
RCAT Yearly Net Income VS EBIT VS OCF VS FCFRCAT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -20M -40M -60M -80M

1.2 Ratios

  • With a Return On Assets value of -26.34%, RCAT is not doing good in the industry: 83.75% of the companies in the same industry are doing better.
  • The Return On Equity of RCAT (-29.32%) is worse than 78.75% of its industry peers.
Industry RankSector Rank
ROA -26.34%
ROE -29.32%
ROIC N/A
ROA(3y)-40.3%
ROA(5y)-49.58%
ROE(3y)-44.71%
ROE(5y)-80.07%
ROIC(3y)N/A
ROIC(5y)N/A
RCAT Yearly ROA, ROE, ROICRCAT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1K -1K 2K

1.3 Margins

  • The Gross Margin of RCAT (3.13%) is worse than 86.25% of its industry peers.
  • In the last couple of years the Gross Margin of RCAT has declined.
  • The Profit Margin and Operating Margin are not available for RCAT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 3.13%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-39.98%
GM growth 5Y-31%
RCAT Yearly Profit, Operating, Gross MarginsRCAT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -500 -1K -1.5K -2K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. RCAT Health Analysis

2.1 Basic Checks

  • RCAT does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, RCAT has more shares outstanding
  • The number of shares outstanding for RCAT has been increased compared to 5 years ago.
  • RCAT has a worse debt/assets ratio than last year.
RCAT Yearly Shares OutstandingRCAT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
RCAT Yearly Total Debt VS Total AssetsRCAT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M

2.2 Solvency

  • RCAT has an Altman-Z score of 29.86. This indicates that RCAT is financially healthy and has little risk of bankruptcy at the moment.
  • With an excellent Altman-Z score value of 29.86, RCAT belongs to the best of the industry, outperforming 95.00% of the companies in the same industry.
  • A Debt/Equity ratio of 0.02 indicates that RCAT is not too dependend on debt financing.
  • With an excellent Debt to Equity ratio value of 0.02, RCAT belongs to the best of the industry, outperforming 90.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Altman-Z 29.86
ROIC/WACCN/A
WACC9.99%
RCAT Yearly LT Debt VS Equity VS FCFRCAT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M

2.3 Liquidity

  • A Current Ratio of 15.29 indicates that RCAT has no problem at all paying its short term obligations.
  • With an excellent Current ratio value of 15.29, RCAT belongs to the best of the industry, outperforming 96.25% of the companies in the same industry.
  • RCAT has a Quick Ratio of 13.24. This indicates that RCAT is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Quick ratio value of 13.24, RCAT belongs to the best of the industry, outperforming 96.25% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 15.29
Quick Ratio 13.24
RCAT Yearly Current Assets VS Current LiabilitesRCAT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. RCAT Growth Analysis

3.1 Past

  • The earnings per share for RCAT have decreased strongly by -95.00% in the last year.
  • RCAT shows a strong growth in Revenue. In the last year, the Revenue has grown by 280.71%.
  • Measured over the past years, RCAT shows a very strong growth in Revenue. The Revenue has been growing by 152.10% on average per year.
EPS 1Y (TTM)-95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-88.89%
Revenue 1Y (TTM)280.71%
Revenue growth 3Y85.03%
Revenue growth 5Y152.1%
Sales Q2Q%315.8%

3.2 Future

  • Based on estimates for the next years, RCAT will show a quite strong growth in Earnings Per Share. The EPS will grow by 13.21% on average per year.
  • Based on estimates for the next years, RCAT will show a very strong growth in Revenue. The Revenue will grow by 58.33% on average per year.
EPS Next Y50.83%
EPS Next 2Y32.18%
EPS Next 3Y13.21%
EPS Next 5YN/A
Revenue Next Year286.26%
Revenue Next 2Y133.55%
Revenue Next 3Y78.42%
Revenue Next 5Y58.33%

3.3 Evolution

  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
RCAT Yearly Revenue VS EstimatesRCAT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 50M 100M 150M 200M
RCAT Yearly EPS VS EstimatesRCAT Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 -0.2 -0.4 -0.6

More info and screens

Find the best growth stocksShow best growing peers

0

4. RCAT Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for RCAT. In the last year negative earnings were reported.
  • Also next year RCAT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
RCAT Price Earnings VS Forward Price EarningsRCAT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
RCAT Per share dataRCAT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 1.5 2

4.3 Compensation for Growth

  • RCAT's earnings are expected to grow with 13.21% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y32.18%
EPS Next 3Y13.21%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. RCAT Dividend Analysis

5.1 Amount

  • No dividends for RCAT!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

RCAT Fundamentals: All Metrics, Ratios and Statistics

RED CAT HOLDINGS INC

NASDAQ:RCAT (5/1/2026, 8:00:01 PM)

After market: 11.25 +0.02 (+0.18%)

11.23

-0.49 (-4.18%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Industry StrengthN/A
Industry GrowthN/A
Earnings (Last)03-18
Earnings (Next)05-07
Inst Owners40.01%
Inst Owner Change1.45%
Ins Owners11.35%
Ins Owner Change0.07%
Market Cap1.36B
Revenue(TTM)40.73M
Net Income(TTM)-72.08M
Analysts84
Price Target19.64 (74.89%)
Short Float %27.16%
Short Ratio1.8
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-48.69%
Min EPS beat(2)-86.27%
Max EPS beat(2)-11.11%
EPS beat(4)0
Avg EPS beat(4)-69.34%
Min EPS beat(4)-152.1%
Max EPS beat(4)-11.11%
EPS beat(8)1
Avg EPS beat(8)-67.13%
EPS beat(12)1
Avg EPS beat(12)-92.66%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-17.88%
Min Revenue beat(2)-43.29%
Max Revenue beat(2)7.53%
Revenue beat(4)1
Avg Revenue beat(4)-32.08%
Min Revenue beat(4)-59.15%
Max Revenue beat(4)7.53%
Revenue beat(8)2
Avg Revenue beat(8)-20.49%
Revenue beat(12)4
Avg Revenue beat(12)-17.03%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)13.24%
PT rev (3m)28.33%
EPS NQ rev (1m)0%
EPS NQ rev (3m)9.48%
EPS NY rev (1m)1.91%
EPS NY rev (3m)1.91%
Revenue NQ rev (1m)-11.94%
Revenue NQ rev (3m)-20.69%
Revenue NY rev (1m)5.77%
Revenue NY rev (3m)5.79%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 33.4
P/FCF N/A
P/OCF N/A
P/B 5.53
P/tB 6.15
EV/EBITDA N/A
EPS(TTM)-0.78
EYN/A
EPS(NY)-0.38
Fwd EYN/A
FCF(TTM)-0.79
FCFYN/A
OCF(TTM)-0.74
OCFYN/A
SpS0.34
BVpS2.03
TBVpS1.83
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -26.34%
ROE -29.32%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 3.13%
FCFM N/A
ROA(3y)-40.3%
ROA(5y)-49.58%
ROE(3y)-44.71%
ROE(5y)-80.07%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-39.98%
GM growth 5Y-31%
F-Score4
Asset Turnover0.15
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 293.47%
Cap/Sales 16.32%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 15.29
Quick Ratio 13.24
Altman-Z 29.86
F-Score4
WACC9.99%
ROIC/WACCN/A
Cap/Depr(3y)188.96%
Cap/Depr(5y)N/A
Cap/Sales(3y)14.17%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-88.89%
EPS Next Y50.83%
EPS Next 2Y32.18%
EPS Next 3Y13.21%
EPS Next 5YN/A
Revenue 1Y (TTM)280.71%
Revenue growth 3Y85.03%
Revenue growth 5Y152.1%
Sales Q2Q%315.8%
Revenue Next Year286.26%
Revenue Next 2Y133.55%
Revenue Next 3Y78.42%
Revenue Next 5Y58.33%
EBIT growth 1Y-120.55%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year39.83%
EBIT Next 3Y17.08%
EBIT Next 5Y21.69%
FCF growth 1Y-408.89%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-380.19%
OCF growth 3YN/A
OCF growth 5YN/A

RED CAT HOLDINGS INC / RCAT Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for RED CAT HOLDINGS INC?

ChartMill assigns a fundamental rating of 3 / 10 to RCAT.


What is the valuation status for RCAT stock?

ChartMill assigns a valuation rating of 0 / 10 to RED CAT HOLDINGS INC (RCAT). This can be considered as Overvalued.


What is the profitability of RCAT stock?

RED CAT HOLDINGS INC (RCAT) has a profitability rating of 0 / 10.


What is the earnings growth outlook for RED CAT HOLDINGS INC?

The Earnings per Share (EPS) of RED CAT HOLDINGS INC (RCAT) is expected to grow by 50.83% in the next year.